Centiva Capital’s Forbion European Acquisition Corp. Class A Ordinary Shares FRBN Stock Holding History

Centiva Capital’s Portfolio FRBN Stock Details FRBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-160,065	Closed	-$1.75M	–	2391
2023 Q3	$1.75M	Hold	160,065	–	–	0.04%	428
2023 Q2	$1.72M	Hold	160,065	–	–	0.04%	424
2023 Q1	$1.69M	Hold	160,065	–	–	0.04%	455
2022 Q4	$1.66M	Hold	160,065	–	–	0.05%	413
2022 Q3	$1.62M	Sell	160,065 -90,616	-36%	-$911K	0.03%	427
2022 Q2	$2.51M	Buy	250,681 +681	+0.3%	+$6.79K	0.06%	303
2022 Q1	$2.49M	Buy	+250,000	New	+$2.48M	0.05%	360

Centiva Capital's FRBN Position: Q4 2023 in Review

Centiva Capital sold out of Forbion European Acquisition Corp. Class A Ordinary Shares (FRBN) in Q4 2023, closing a stake of 160,065 shares — an estimated $1.75M sold.

Centiva Capital first reported a position in FRBN in Q1 2022 and held it in 7 quarters. The position peaked at $2.51M in Q2 2022. 0 funds tracked by Wall St. Rank hold FRBN as of Q4 2023.

Centiva Capital reported no remaining Forbion European Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Centiva Capital sold 160,065 Forbion European Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $1.75M.
Centiva Capital first reported a position in Forbion European Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
Centiva Capital's Forbion European Acquisition Corp. Class A Ordinary Shares position peaked at $2.51M in Q2 2022.
0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Centiva Capital's 13F filing for Q4 2023, filed 14 Feb 2024.